Nearly one in six people worldwide needlessly suffer from neglected tropical diseases (NTDs), yet a tremendous need for research and development of new products to treat and protect against these debilitating diseases still exists.

Dr. Albert B. Sabin is best known for developing the oral live virus polio vaccine, but his legacy extends far beyond this single groundbreaking medical advancement.

Sabin is happy to announce the arrival of our 2012 Annual Report, featuring highlights from our three programs – Vaccine Advocacy and Education, The Sabin Product Development Partnership, and the Global Network for Neglected Tropical Diseases.

Human hookworm, schistosomiasis, Chagas disease and leishmaniasis are some of the most devastating diseases in poverty with no licensed vaccine available.

Reposted with permission from the TAMEST blog, which is run by the Academy of Medicine, Engineering & Science of Texas. 

Last Friday, the G8 Lough Erne Accountability Report was released by the UK government in the lead-up to the G8 summit happening at the end of this week.

Neglected Tropical Diseases (NTDs) are an important health issue in countries around the world. Most people don’t think about them at all, let alone know that some NTDs are also prevalent in the United States. The emerging threat of NTDs at home has been gaining attention recently, such as in this recent article, which appeared online in Discover.

Field research, such as that conducted for clinical trials or disease surveillance, is essential to address the many pervasive health issues in developing countries. It relies on extensive collaboration between research institutions and groups on the ground.

To highlight the extensive body of knowledge collected in developing the Global Vaccine Action Plan (GVAP), the journal Vaccine today released a special supplement dedicated in full to the Decade of Vaccines.
When it comes to scientific research, not all schistosomes are treated equally.

Pages